Introduction

Erectile dysfunction (ED) happens when a man struggles to get or keep an erection firm enough for sexual activity. This condition can result from issues with nerves, blood flow, hormones, or mental health. ED is common, especially as men age, with about 37% of men aged 70–75 experiencing it.

Standard ED treatments include medications like phosphodiesterase-5 inhibitors (PDE5is, oral ED medications), injections, vacuum devices, or even surgery (e.g., penile implants). While effective, some men stop using these treatments due to side effects or reduced effectiveness over time.

Recently, interest has grown in regenerative therapies, which aim to repair and restore natural function. These include stem cell therapy (SCT), platelet-rich plasma (PRP) injections, and low-intensity shockwave therapy (LiSWT). However, it’s unclear how these newer treatments compare in effectiveness to established treatments.

This study reviewed existing research to compare these regenerative therapies using advanced statistical methods. It evaluated their impact on improving erectile function using the International Index of Erectile Function (IIEF), a standard measurement tool for ED outcomes. The findings aim to guide future research and help doctors and patients make informed decisions about these emerging treatment options.

Methods

In January 2024, researchers conducted a detailed search across major databases (e.g., PubMed, MEDLINE, Scopus) to find studies on regenerative therapies for ED. They looked for randomized controlled trials (RCTs) comparing LiSWT, PRP therapy, and SCT with standard treatments or placebo. The main goal was to measure their impact on erectile function using the widely accepted IIEF, with secondary outcomes like blood flow to the penis assessed via Doppler imaging.

To ensure accuracy, the researchers evaluated the quality of studies, compared treatment effects, and addressed differences in how outcomes were reported. They also explored how factors like drug doses or the use of PDE5 inhibitors influenced results. The study used sophisticated tools to rank treatments and identify which therapies might offer the best outcomes, with higher scores indicating better potential benefits.

Results

Ultimately, this study analyzed 16 clinical trials involving 907 patients to evaluate regenerative therapies for ED. Of these, 10 patients received SCT, 100 received PRP, 370 underwent LiSWT, and 427 served as controls.

There was only one SCT study included, with 10 patients receiving stem cells and 10 in the control group. Patients in the PRP group received different injection protocols: two injections of 10 milliliters (30 patients), three injections of 6 milliliters (50 patients), and two injections of 5 milliliters (20 patients). For LiSWT, treatments varied by energy intensity: 233 patients received 0.09 mJ, 95 received 0.15 mJ, and 42 received 0.2 mJ. All treatments were monitored for improvements in ED severity using standardized measures like the IIEF.

Results showed that patients in all treatment groups experienced varying levels of improvement compared to controls, with differences depending on treatment type, dosage, and severity of ED. Here’s a breakdown of each treatment:

Low-Intensity Shockwave Therapy (LiSWT):

• LiSWT improved IIEF scores significantly, especially at a dose of 0.15 mJ/mm², which showed the most substantial effect.
• It helps by improving blood flow and stimulating new blood vessel formation.
• Peak systolic velocity (PSV), an indicator of better blood flow in the penis, also increased significantly with LiSWT.

Platelet-Rich Plasma (PRP):

• PRP also led to notable IIEF improvements, with concentrated doses showing positive results.
• It works by delivering growth factors that promote tissue healing and blood vessel formation.
• Like LiSWT, PRP significantly improved PSV, indicating better blood flow.

Stem Cell Therapy (SCT):

• SCT showed the largest overall improvement in IIEF scores among the three treatments, although the data has some inconsistencies.
• It helps by repairing damaged tissues and reducing inflammation, contributing to improved erectile function.

Discussion & Conclusion

These results highlight the potential of these therapies to enhance erectile function. However, while promising, these treatments’ effectiveness varies based on patient differences, treatment protocols, and study designs. More research is needed to clarify their long-term benefits, ideal doses, and clinical significance.

The analysis noted other challenges as well, including variability in study methods, potential biases, and the need for standardized measures of treatment success. Future studies should include objective evaluations and long-term follow-ups to better understand the real-world impact of these therapies.

References:

• Hinojosa-Gonzalez, D. E., Saffati, G., Orozco Rendon, D., La, T., Kronstedt, S., Muthigi, A., & Khera, M. (2024). Regenerative therapies for erectile dysfunction: A systematic review, Bayesian network meta-analysis, and meta-regression. The Journal of Sexual Medicine, 21(12), 1152–1158. https://doi.org/10.1093/jsxmed/qdae131